Dr. Wendy Parulekar is a graduate of the University of Ottawa Medical School where she also completed residency training in Internal Medicine and Medical Oncology followed by post graduate training in clinical pharmacology at the Odette Cancer Centre. She currently holds a joint clinical/research position at Queen's University Cancer Research Institute and is a member of multiple international scientific advisory committees. Trials in her portfolio have contributed to treatment guidelines in breast, gynaecological and genitourinary malignancies.
Dr. Parulekar is an active member of the international Society of Clinical Trials and served as President in 2015-2016. Other activities include member of the National Cancer Research Institute (NCRI): International Clinical Trials Awards and Advisory Panel, external protocol reviewer for the European Organization for Research and Treatment of Cancer, reviewer for 12 peer reviewed journals, Associate Editor for Clinical Trials, Steering Committee Member for the OICR Biostatistics Training Initiative and consultant to Health Canada.
Areas of expertise: Clinical Trials, Breast, Head and Neck, Genitourinary, Gynaecology
Research interests: Breast Cancer, Clinical Trial Design and Conduct
Current trials: MA39, BL13, PNC1, PR19, PR20, PR21, PR22, REC3, REC4, ENC1, OV25, OV26, OVC2, HN9, HN10, HNC2
For a full list of publications please visit PubMed